Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder

Roy H. Perlis, Andrew A. Nierenberg, Jonathan E. Alpert, Joel Pava, John D. Matthews, Jaqueline Buchin, Andrea H. Sickinger, Maurizio Fava

Research output: Contribution to journalArticlepeer-review

57 Scopus citations

Fingerprint Dive into the research topics of 'Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder'. Together they form a unique fingerprint.

Medicine & Life Sciences